Eric Lefebvre - 21 Mar 2022 Form 3 Insider Report for CymaBay Therapeutics, Inc.

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Eric Lefebvre
Issuer symbol
N/A
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
3
Filing time
21 Mar 2022, 17:24:11 UTC
Previous filing
02 Feb 2022
Next filing
13 Jul 2022

No securities are beneficially owned.